鲸奇生物

Shanghai-based biotech founded in 2020 developing preclinical gene therapies and regenerative medicines for neurological, ocular, and hearing diseases

Biotech & Life Sciences

Sector

Preclinical therapeutics development

Model

01Company Overview

Shanghai-based biotech founded in 2020 developing preclinical gene therapies and regenerative medicines for neurological, ocular, and hearing diseases. Its approach combines genome-editing technology with regenerative medicine.

02Backed By1 investor

KCKaitai Capital→

03Similar Companies

Is this your company? Claim your profile